Completed OBSERVATIONAL NCT04741412

Pediatric SARS-CoV-2 Infections: Course of COVID-19, Immune Responses, Complications and Long-term Consequences (PEDCOVID-19)

SARS-CoV-2 Infections in Children and Adolescents: Course of COVID-19, Immune Responses, Complications and Long-term Consequences in Entire Households With Members Younger Than 18 Years

Sponsor: University Hospital Erlangen

Conditions Hypohidrotic Ectodermal Dysplasia

Updated 6 times since 2021 Last updated: Aug 13, 2021 Started: Jun 3, 2020 Primary completion: May 31, 2021 Completion: May 31, 2021

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT04741412, this observational or N/A phase trial focuses on Hypohidrotic Ectodermal Dysplasia and remains completed. Sponsored by University Hospital Erlangen, it has been updated 6 times since 2020, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Dec 2021 — Jul 2024 [monthly]

Completed
Sep 2021 — Dec 2021 [monthly]

Completed

Status: Recruiting → Completed
May 2021 — Sep 2021 [monthly]

Recruiting

▶ Show 1 earlier version

Mar 2021 — May 2021 [monthly]

Recruiting

First recorded

Jun 2020

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University Hospital Erlangen

Data source: University Hospital Erlangen

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Erlangen, Germany